BioNTech SE (BNTX) vs Quest Diagnostics Incorporated (DGX)
A side-by-side comparison of BioNTech SE and Quest Diagnostics Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
BNTX
BioNTech SE
$99.26HealthcareDelayed quote: Sep 24, 2026, 4:00 PM EDT
DGX
Quest Diagnostics Incorporated
$236.44HealthcareDelayed quote: Sep 24, 2026, 3:59 PM EDT
Total return — BNTX vs DGX
growth of $100 · dividends reinvested · last 7yBNTX +588.3% (+31.7%/yr)DGX +160.7% (+14.7%/yr)BNTX compounded faster over this window
BNTX DGX
BNTX vs DGX: by the numbers
- •DGX is the larger company ($26.10B vs $24.93B market cap).
- •DGX is profitable (9.19% net margin) while BNTX runs a net loss (-62.98%).
- •BNTX grew revenue faster over the past five years (40.61% vs 0.89% CAGR).
- •DGX pays a dividend (1.41% yield), while BNTX is a former payer with no current dividend run rate.
Metrics side by side
Valuation
| Metric | BNTX | DGX |
|---|---|---|
| P/E ratio | N/A | 25.10 |
| Forward P/E | N/A | 21.13 |
| P/S ratio | 8.05 | 2.26 |
| P/B ratio | 1.23 | 3.47 |
| EV / EBITDA | N/A | 15.95 |
| FCF yield | 2.48% | 4.67% |
Profitability
| Metric | BNTX | DGX |
|---|---|---|
| Gross margin | 70.98% | 33.15% |
| Operating margin | -22.63% | 14.14% |
| Net margin | -62.98% | 9.19% |
| ROE | -9.62% | 14.13% |
| ROIC | -10.37% | 8.25% |
Dividends
| Metric | BNTX | DGX |
|---|---|---|
| Dividend yield | N/A | 1.41% |
| Payout ratio | N/A | 35.24% |
Growth (annualized)
| Metric | BNTX | DGX |
|---|---|---|
| Revenue CAGR (5Y) | 40.61% | 0.89% |
| EPS CAGR (5Y) | N/A | -3.65% |
| FCF CAGR (5Y) | N/A | -10.89% |
| Total return CAGR (5Y) | -22.43% | 10.93% |
Frequently asked
- Which has grown faster, BNTX or DGX?
- Over the past five years, BNTX grew revenue faster — BNTX at a 40.61% CAGR versus DGX at 0.89%.
- Does BNTX or DGX pay a bigger dividend?
- DGX pays a dividend (1.41% yield), while BNTX is a former payer with no current dividend run rate.
- Is BNTX or DGX more profitable?
- DGX runs the higher net margin — BNTX at -62.98% versus DGX at 9.19%.
- How have BNTX and DGX total returns compared?
- Over the past 5 years, BNTX delivered -22.43% and DGX delivered 10.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Quest Diagnostics P/E ratioQuest Diagnostics dividend yieldBioNTech SE ROEQuest Diagnostics ROEBioNTech SE operating marginQuest Diagnostics operating marginBioNTech SE revenue growthQuest Diagnostics revenue growthBioNTech SE free cash flowQuest Diagnostics free cash flow
BioNTech SE & Quest Diagnostics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.